Nano-X Imaging Ltd.
NASDAQ:NNOXMedical - Devices
-$0.03 today
- Market cap
- $50.94M
- Beta
- 1.17
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.12
Volume 0.52M
Average 1.46M
NNOX Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Nano-X Imaging Ltd.NASDAQ: NNOX
Cost of Revenue · Q4 FY2025 · quarter ended Dec 2025
Cost of revenue growth accelerates
Q4 FY2025 cost of revenue of $7.34M rose 24.6% year over year, ahead of the +17.4% change in trailing-twelve-month cost of revenue. Sequentially, it rose 15.9% from the prior quarter. Over 3 fiscal years it compounded at +18.6% a year.
Context
- Cost of revenue amounted to 198.2% of revenue in FY2025, up 4.2 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +24.6% holds above the trailing-twelve-month pace of +17.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 25.81M USD
- Year-over-year change
- +17.9%
- 4-year CAGR
- +74.0%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 25.81M | +17.9% |
| FY2024 | 2024-12-31 | 21.89M | +32.7% |
| FY2023 | 2023-12-31 | 16.5M | +6.7% |
| FY2022 | 2022-12-31 | 15.46M | +448.9% |
| FY2021 | 2021-12-31 | 2.82M | — |
Cost of Revenue vs competitors
How NNOX compares with its peers on the latest reported figures
- NNOX's LTM Dec 2025 cost of revenue of $25.81M is the 5th highest of the 11 companies compared; the peer median is $8.74M.
- Its year-over-year change of +17.4% is the 4th highest of 10, against a peer median of -1.6%.
- Cost of revenue amounts to 198.2% of revenue for NNOX, versus a peer median of 40.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $180.21M | -1.6% | -6.5% | 51.3% | |
| LTM Mar 2026 | $163.38M | -4.2% | +13.1% | 54.0% | |
| LTM Mar 2026 | $80.87M | +47.8% | +7.1% | 55.8% | |
| LTM Mar 2026 | $69.8M | -5.5% | -9.3% | 59.4% | |
| LTM Dec 2025 | $25.81M | +17.4% | +18.6% | 198.2% | |
| LTM Mar 2026 | $10.78M | +27.5% | +32.5% | 24.3% | |
| LTM Mar 2026 | $6.7M | +44.8% | +45.6% | 14.9% | |
| LTM Mar 2026 | $6.23M | -13.4% | +6.9% | 19.3% | |
| LTM Mar 2026 | $5.46M | +17.1% | +9.4% | 28.9% | |
| LTM Mar 2026 | $2.63M | — | — | 426.2% | |
| LTM Mar 2026 | $559K | -3.6% | +2.6% | 5.8% | |
| Peer median (excluding NNOX) | $8.74M | -1.6% | +7.1% | 40.1% | |
Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.3M | 8.58M | 9.91M | 11.28M | 13.02M |
| Cost of Revenue | 2.82M | 15.46M | 16.5M | 21.89M | 25.81M |
| Gross Profit | (1.51M) | (6.88M) | (6.59M) | (10.61M) | (12.79M) |
| Gross Margin | -116.0% | -80.2% | -66.6% | -94.0% | -98.2% |
| Research & Development | 17.12M | 26.51M | 26.05M | 20.18M | 19.24M |
| Selling, General & Admin | 41.74M | 45.63M | 28.39M | 25.75M | 27.1M |
| Operating Expenses | 60.05M | 72.33M | 56M | 46.14M | 47.91M |
| Depreciation & Amortization | 2.29M | 11.51M | 11.81M | 11.73M | 11.7M |
| EBITDA | (59.27M) | (75.7M) | (47.69M) | (45.01M) | (49M) |
| EBITDA Margin | -4544.9% | -882.4% | -481.5% | -398.9% | -376.3% |
| Operating Income | (61.56M) | (109.71M) | (62.59M) | (56.75M) | (60.7M) |
| Operating Margin | -4720.7% | -1279.0% | -631.9% | -502.9% | -466.2% |
| Interest Income | 0 | 789K | 1.65M | 2.87M | 1.42M |
| Interest Expense | 288K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (288K) | (14.67M) | 1.47M | 2.87M | (16.11M) |
| Income Before Tax | (61.85M) | (108.92M) | (61.12M) | (53.87M) | (76.81M) |
| Pre-Tax Margin | -4742.8% | -1269.8% | -617.0% | -477.5% | -589.9% |
| Income Tax Expense | (48K) | (3.68M) | (339K) | (358K) | (1.79M) |
| Net Income | (61.8M) | (105.24M) | (60.78M) | (53.52M) | (75.02M) |
| Net Margin | -4739.1% | -1226.9% | -613.6% | -474.3% | -576.1% |
| EPS (Basic) | (1.28) | (2.01) | (1.08) | (0.91) | (1.16) |
| EPS (Diluted) | (1.28) | (2.01) | (1.08) | (0.91) | (1.16) |
| Weighted Avg Shares | 48.22M | 52.24M | 56.37M | 58.62M | 64.79M |
| Weighted Avg Shares (Diluted) | 48.22M | 52.24M | 56.37M | 58.62M | 64.79M |
Nano-X Imaging Ltd.
NASDAQ:NNOX
Intrinsic Alpha fair value
Locked
Current Price
$0.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.